Primary membranous nephropathy — RCPSC IM MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Start immunosuppressive therapy such as rituximab after risk assessment
Persistent high-risk primary membranous nephropathy despite optimized supportive care warrants immunosuppressive therapy, commonly rituximab-based, after individualized risk and infection assessment.
Reference: KDIGO glomerular disease guidance